For the quarter ending 2026-03-31, GKOS has $893,326K in assets. $222,398K in debts. $104,249K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 104,249 | 90,813 | 98,246 | 100,813 |
| Short-term investments | 172,436 | 187,947 | 175,466 | 173,973 |
| Accounts receivable, net | 119,691 | 108,608 | 98,684 | 82,985 |
| Inventory | 62,384 | 63,564 | 63,863 | 64,621 |
| Prepaid expenses and other current assets | 26,993 | 24,052 | 18,509 | 13,673 |
| Total current assets | 485,753 | 474,984 | 454,768 | 436,065 |
| Restricted cash | 3,834 | 3,834 | 3,834 | 3,834 |
| Property and equipment, gross | - | 168,792 | - | - |
| Less accumulated depreciation and amortization | - | 55,539 | - | - |
| Property and equipment, net | 112,432 | 113,253 | 110,944 | 111,816 |
| Operating lease right-of-use asset | 31,025 | 31,527 | 31,536 | 31,985 |
| Finance lease right-of-use asset | 38,800 | 39,404 | 40,007 | 40,610 |
| Finite lived - gross amount | - | 143,157 | - | - |
| Finite lived - accumulated amortization | - | 8,441 | - | - |
| Finite lived - net amount | - | 134,716 | - | - |
| Indefinite lived assets-In Process Research And Development | - | 7,200 | - | - |
| Intangible assets, net | 133,028 | 141,916 | 264,136 | 270,491 |
| Goodwill | 66,710 | 66,710 | 66,710 | 66,710 |
| Deposits and other assets | 21,744 | 21,859 | 27,443 | 25,447 |
| Total assets | 893,326 | 893,487 | 999,378 | 986,958 |
| Accounts payable | 19,153 | 24,624 | 19,883 | 13,684 |
| Accrued liabilities | 70,262 | 76,651 | 67,633 | 65,452 |
| Total current liabilities | 89,415 | 101,275 | 87,516 | 79,136 |
| Operating lease liability | 35,313 | 35,767 | 35,847 | 36,200 |
| Finance lease liability | 67,743 | 68,109 | 68,468 | 68,823 |
| Deferred tax liability, net | 441 | 441 | 6,921 | 6,910 |
| Other liabilities | 29,486 | 31,740 | 31,083 | 30,777 |
| Total liabilities | 222,398 | 237,332 | 229,835 | 221,846 |
| Common stock, 0.001 par value 150,000 shares authorized 58,387 and 57,539 shares issued and 58,359 and 57,511 shares outstanding as of march 31, 2026 and december 31, 2025, respectively | 58 | 58 | 57 | 57 |
| Additional paid-in capital | 1,621,272 | 1,586,056 | 1,566,029 | 1,545,557 |
| Accumulated other comprehensive income | 2,643 | 3,303 | 3,062 | 2,872 |
| Accumulated deficit | -952,913 | -933,130 | -799,473 | -783,242 |
| Less treasury stock (28 shares as of march 31, 2026 and december 31, 2025) | 132 | 132 | 132 | 132 |
| Total stockholders' equity | 670,928 | 656,155 | 769,543 | 765,112 |
| Total liabilities and stockholders' equity | 893,326 | 893,487 | 999,378 | 986,958 |
GLAUKOS Corp (GKOS)
GLAUKOS Corp (GKOS)